ReviewEndocrine oncology (Bristol, England)2025

HHLA2: a potential biomarker and therapeutic target in endocrine-related cancer.

Christiane Gruetzmacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.